Try it
Pharmacology · Lipid drugs: ezetimibe
Sample itemA patient with LDL cholesterol above target on maximal statin therapy is given an add-on drug that blocks intestinal cholesterol absorption. Which target does it act on?
Original practice item, not a recalled exam question. Nothing here is recorded.
The answer and the reasoning
A. Niemann-Pick C1-like 1 protein
Ezetimibe inhibits the NPC1L1 transporter in the enterocyte brush border and lowers LDL by about 15 to 20 percent. It is additive to statins and well tolerated.
Option by option
A. Niemann-Pick C1-like 1 protein (correct)
Correct. Ezetimibe blocks NPC1L1.
B. ATP citrate lyase
ATP citrate lyase is inhibited by bempedoic acid.
C. PPAR-alpha receptor
PPAR-alpha is activated by fibrates.
D. HMG-CoA reductase
HMG-CoA reductase is the statin target.
Source note: Original NextPrep sample item — pending expert review. This item is original practice material awaiting independent expert review, so confirm important facts in a standard textbook.
More Pharmacology questions
- Emergency drugsA patient develops stridor, wheeze and hypotension minutes after an injection. What is t…
- AntiepilepticsWhat is the preferred first-line drug for a patient in generalised convulsive status epi…
- AntimicrobialsWhich drug can cause a disulfiram-like reaction when taken with alcohol?
- AntiepilepticsWhich drug is preferred for uncomplicated childhood absence seizures?